Literature DB >> 31116637

Seroepidemiology of pertussis in Hangzhou, China, during 2009-2017.

Yuyang Xu1, Erping Xu1, Shijun Liu1, Wei Zheng1, Xuechao Zhang1, Jian Du1, Xiaoping Zhang1, Jun Wang1, Xinren Che1, Wenwen Gu1, Yan Liu1.   

Abstract

Objective: To delineate seroepidemiology of pertussis in Hangzhou, to evaluate the protection levels of pertussis among healthy populations, for improving prevention strategy of pertussis.
Methods: During 2009-2017, a multistage stratified random sampling method was employed to select participants included via physical examination for subjects in several Community Health Centers in Hangzhou. Enzyme-Linked Immunosorbent Assay (ELISA) was used to detect Immunoglobulin G (IgG) antibodies against pertussis in serum samples. Results were compared among 11 age groups. Univariate and multivariate analysis were used to analyze the associations among the rates of pertussis IgG seropositivity and the geometric mean concentration (GMC) levels of pertussis IgG and the related factors.
Results: A total of 3360 subjects with available information were included, with 1745 male and 1615 female. Of these, 59.6% subjects had a clear immunization history of diphtheria-tetanus-pertussis vaccine (DTP). The vaccination rates of DTP had a declined trend with older age. The rate of pertussis IgG seropositivity was 69.9% (95% confidence interval: 68.3-71.5) and the GMC for pertussis IgG was 48.46 U/ml. Significantly higher seropositivity and GMC for pertussis IgG were found in subjects that had inoculation vaccine history or unknown history when compared those without inoculation of vaccine, lower in age groups <10, 20-29, and 30-39 y when compared to the other age groups evaluated.Conclusions: There are different distribution profiles both of the seropositivity and GMC for pertussis IgG for different age groups and immunization history of vaccine groups. In order to prevent pertussis occurrence, it is important to employ a booster dose of pertussis vaccine in adolescents and adults.

Entities:  

Keywords:  Pertussis; immunological response; seroepidemiology; vaccine

Mesh:

Substances:

Year:  2019        PMID: 31116637      PMCID: PMC6930058          DOI: 10.1080/21645515.2019.1608130

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  23 in total

1.  DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.

Authors:  Kazunari Kamachi; Toshifumi Konda; Yoshichika Arakawa
Journal:  Vaccine       Date:  2003-11-07       Impact factor: 3.641

2.  Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.

Authors:  H Theeten; V Hutse; N Hens; Y Yavuz; K Hoppenbrouwers; P Beutels; R Vranckx; P Van Damme
Journal:  Epidemiol Infect       Date:  2010-06-29       Impact factor: 2.451

3.  Pertussis vaccines: WHO position paper, August 2015--Recommendations.

Authors: 
Journal:  Vaccine       Date:  2015-11-10       Impact factor: 3.641

Review 4.  Immunosenescence: Implications for vaccination programmes in adults.

Authors:  Pierre Olivier Lang; Sheila Govind; Jean Pierre Michel; Richard Aspinall; Wayne A Mitchell
Journal:  Maturitas       Date:  2011-02-12       Impact factor: 4.342

5.  Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.

Authors:  Maxwell A Witt; Paul H Katz; David J Witt
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

6.  Waning protection after fifth dose of acellular pertussis vaccine in children.

Authors:  Nicola P Klein; Joan Bartlett; Ali Rowhani-Rahbar; Bruce Fireman; Roger Baxter
Journal:  N Engl J Med       Date:  2012-09-13       Impact factor: 91.245

7.  [Observation of immunity level of pertussis-diphtheria-tetanus in healthy people in Hangzhou City during 1995-2006].

Authors:  Li-Ming Huang; Er-Ping Xu; Luo-Xian Yang
Journal:  Zhongguo Yi Miao He Mian Yi       Date:  2009-02

8.  Pertussis epidemic--California, 2014.

Authors:  Kathleen Winter; Carol Glaser; James Watt; Kathleen Harriman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-05       Impact factor: 17.586

9.  A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak.

Authors:  Yulanda M Williamson; Hercules Moura; Jennifer Whitmon; Adrian R Woolfitt; David M Schieltz; Jon C Rees; Stephanie Guo; Heather Kirkham; Daniel Bouck; Edwin W Ades; Maria Lucia Tondella; George M Carlone; Jacquelyn S Sampson; John R Barr
Journal:  Int J Proteomics       Date:  2015-05-24

10.  Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

Authors:  Pádraig J Ross; Caroline E Sutton; Sarah Higgins; Aideen C Allen; Kevin Walsh; Alicja Misiak; Ed C Lavelle; Rachel M McLoughlin; Kingston H G Mills
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more
  1 in total

1.  Risk factors and prediction model of severe pertussis in infants < 12 months of age in Tianjin, China.

Authors:  Cui Zhang; Yanmei Zong; Ying Li; Yuejie Yang; Zhe Wang; Li Wang
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.